History shows that women’s healthcare has often taken a back seat. Dating back centuries—to the early days of documentation—women have been left out of …
Women’s History Month: the evolution of women’s health screening Read More »
X-Therma, a member of the Biotechnology Innovation Organization (BIO), recently announced significant strides towards changing the future of organ preservation and transportation. On March …
X-Therma hints at what’s next: a revolution in organ transplantation and preservation Read More »
The Covid-19 pandemic undoubtedly reshaped the landscape of healthcare and vaccine development in ways we have yet to imagine. As we navigate through another …
The future of pandemic defense leverages science and tech Read More »
A 70-year-old female presents to the emergency department with chest pain. Her husband of 50 years died suddenly earlier in the day. Her pain …
The science behind broken heart syndrome’s health effects Read More »
Four years after the start of the pandemic, it is well known that COVID-19 is linked with thrombosis. A new report from the Centers …
CDC report: up-to-date COVID-19 vaccinations can protect against severe outcomes Read More »
In October 2023, Genentech announced results from the first-ever clinical trial designed exclusively to enhance the knowledge base supporting the Black and Hispanic population …
Genentech Q&A: Improving MS treatment and clinical trial diversity Read More »
Multiple sclerosis (MS) has long been known as an unpredictable, debilitating, and hard-to-pin-down autoimmune disease of the central nervous system. MS affects approximately 2.8 …
Immunic’s bid to improve the treatment of multiple sclerosis Read More »
The U.S. is now entering its fourth season with COVID, and the new vaccination roll-out has begun, including the option of the highly anticipated …
Novavax’s Choose to Protect campaign is dedicated to driving COVID vaccination Read More »
Did you know that every 10 minutes, a new person is added to the organ transplant waiting list? According to the United Network for …
How X-Therma is stopping the clock – and fundamentally changing organ transplantation Read More »
In September, the Food and Drug Administration (FDA) announced priority review of sotatercept, Merck’s activin signaling inhibitor for the treatment of adults with pulmonary …
A promising new treatment for patients with pulmonary arterial hypertension Read More »
